Skip to main content
Log in

Chemical reactivity of cisplatin bound to human plasma proteins

  • Original Articles
  • Cisplatin
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

Human plasma was incubated with cisplatin over 24h. Ultrafilterable platinum and platinum reactive with DDTC were determined at regular time intervals during incubation. At each time point more platinum reacted with sodiumN,N 1-diethyldithiocarbamate (DDTC) than was available as ultrafilterable platinum. At 24 h 70% of total platinum (10% ultrafiltrable platinum and 60% protein-bound platinum) reacted with DDTC. This means that cisplatin bound to plasma proteins can — at least in part — still react with strong nucleophiles.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bannister SJ, Chang Y, Sternson LA, Repta AJ (1978) Atomic absorption spectrophotometry of free circulating platinum species in plasma derived fromcis-dichlorodiammineplatinum (II). Clin Chem 24: 877

    Google Scholar 

  2. Bannister SJ, Sternson LA, Repta AJ (1979) Urine analysis of platinum species derived from cDDP by HPLC following derivatization with DDTC. J Chromatogr 173: 333

    Google Scholar 

  3. Gale GL, Atkins LM, Walker EM (1982) Further evaluation of diethyldithiocarbamate as an antagonist of cisplatin toxicity. Ann Clin Lab Sci 12: 345

    Google Scholar 

  4. Gullo JJ, Litterst CL, Maguire PJ, Sikic BI, Hoth DF, Woolley PV (1980) Pharmacokinetics and protein binding ofcis-dichlorodiammineplatinum (II) administered as a one hour or as a twenty hours infusion. Cancer Chemother Pharmacol 5: 21

    Google Scholar 

  5. Repta AJ, Long DF (1980) Reaction of cisplatin with human plasma and plasma fractions. In: Prestayko AW, Crooke ST, Carter SK (eds) Cisplatin, Current status and new developments. Academic Press, London, p 285

    Google Scholar 

  6. Takahashi K, Seki T, Nishikawa K, Minamide S, Iwabuchi M, Ono M, Nagamine S, Horinishi H (1985) Antitumor activity and toxicity of serum protein-bound platinum formed from cisplatin. Gann 76: 68

    Google Scholar 

  7. Van der Vijgh WJF, Klein I (1986) Protein binding of five platinum compounds. Comparison of two ultrafiltration systems. Cancer Chemother Pharmacol 10: 129

    Google Scholar 

  8. Vermorken JB, van der Vijgh WJF, Klein I, Hart AAM, Gall HE, Pinedo HM (1984) Pharmacokinetics of free and total platinum species after short-term infusion of Cisplatin. Cancer Treat Rep 68: 505

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hegedüs, L., van der Vijgh, W.J.F., Klein, I. et al. Chemical reactivity of cisplatin bound to human plasma proteins. Cancer Chemother. Pharmacol. 20, 211–212 (1987). https://doi.org/10.1007/BF00570487

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00570487

Keywords

Navigation